Author | Norman E. Sharpless, MD | OncLive

Author | Norman E. Sharpless, MD


Dr. Sharpless on Managing Toxicities With Nivolumab and Ipilimumab in Melanoma

May 05, 2016


Norman E. Sharpless, MD, professor of Medicine and Genetics, chair, the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, UNC School of Medicine, discusses how oncologists can best manage toxicities associated with the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of patients with melanoma.